Clinical Trials Browser

Phase 2 × Withdrawn × pemigatinib × Clear all

NCT05216120 2023-07-03

Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms